Patents Assigned to Nexus Pharmaceuticals, Inc.

Compositions comprising ephedrine or an ephedrine salt and methods of making and using same

Patent number: 11571398

Abstract: The present disclosure provides compositions comprising ephedrine sulfate ready for immediate use in a clinical setting, and methods of making and using same.

Type: Grant

Filed: September 12, 2022

Date of Patent: February 7, 2023

Assignee: Nexus Pharmaceuticals, Inc.

Inventor: Shahid Ahmed
Compositions comprising ephedrine or an ephedrine salt and methods of making and using same

Patent number: 11478436

Abstract: The present disclosure provides compositions comprising ephedrine sulfate ready for immediate use in a clinical setting, and methods of making and using same.

Type: Grant

Filed: May 6, 2022

Date of Patent: October 25, 2022

Assignee: Nexus Pharmaceuticals; Inc.

Inventor: Shahid Ahmed
Compositions comprising ephedrine or an ephedrine salt and methods of making and using same

Patent number: 11464752

Abstract: The present disclosure provides compositions comprising ephedrine sulfate ready for immediate use in a clinical setting, and methods of making and using same.

Type: Grant

Filed: July 21, 2021

Date of Patent: October 11, 2022

Assignee: Nexus Pharmaceuticals, Inc.

Inventor: Shahid Ahmed
Compositions comprising ephedrine or an ephedrine salt and methods of making and using same

Patent number: 11426369

Abstract: The present disclosure provides compositions comprising ephedrine sulfate ready for immediate use in a clinical setting, and methods of making and using same.

Type: Grant

Filed: December 20, 2021

Date of Patent: August 30, 2022

Assignee: Nexus Pharmaceuticals, Inc.

Inventor: Shahid Ahmed
Compositions comprising ephedrine or an ephedrine salt and methods of making and using same

Patent number: 11241400

Abstract: The present disclosure provides compositions comprising ephedrine sulfate ready for immediate use in a clinical setting, and methods of making and using same.

Type: Grant

Filed: September 2, 2021

Date of Patent: February 8, 2022

Assignee: Nexus Pharmaceuticals, Inc.

Inventor: Shahid Ahmed
Compositions comprising ephedrine or an ephedrine salt and methods of making and using same

Patent number: 11090278

Abstract: The present disclosure provides compositions comprising ephedrine sulfate ready for immediate use in a clinical setting, and methods of making and using same.

Type: Grant

Filed: May 16, 2020

Date of Patent: August 17, 2021

Assignee: Nexus Pharmaceuticals, Inc.

Inventor: Shahid Ahmed

Compositions comprising ephedrine or an ephedrine salt and methods of making and using same

Compositions comprising ephedrine or an ephedrine salt and methods of making and using same

Compositions comprising ephedrine or an ephedrine salt and methods of making and using same

Compositions comprising ephedrine or an ephedrine salt and methods of making and using same

Compositions comprising ephedrine or an ephedrine salt and methods of making and using same

Compositions comprising ephedrine or an ephedrine salt and methods of making and using same